Which muscle relaxant causes slight histamine release at 2 to 3 times the ED95 dose?

Prepare for the Hall Anesthesia Test. Study with interactive questions and detailed explanations. Ace your exam with confidence!

Multiple Choice

Which muscle relaxant causes slight histamine release at 2 to 3 times the ED95 dose?

Explanation:
Direct histamine release is a known, dose-related side effect of certain benzylisoquinolinium neuromuscular blockers. Among these agents, atracurium is the one most commonly associated with histamine release, which can lead to vasodilation and hypotension. At higher dosing—around two to three times the ED95, the dose needed to achieve 95% neuromuscular blockade—the histamine release tends to be mild rather than severe. This pattern fits the scenario described, making atracurium the best answer. Other agents in this class (and most commonly used alternatives) have minimal histamine release at typical clinical doses, which is why they don’t fit the description as well. The underlying idea is that atracurium can provoke mast cell degranulation directly, not through histamine-releasing receptors, and clinicians often choose slower administration or an alternative agent if histamine-related effects are a concern.

Direct histamine release is a known, dose-related side effect of certain benzylisoquinolinium neuromuscular blockers. Among these agents, atracurium is the one most commonly associated with histamine release, which can lead to vasodilation and hypotension. At higher dosing—around two to three times the ED95, the dose needed to achieve 95% neuromuscular blockade—the histamine release tends to be mild rather than severe. This pattern fits the scenario described, making atracurium the best answer. Other agents in this class (and most commonly used alternatives) have minimal histamine release at typical clinical doses, which is why they don’t fit the description as well. The underlying idea is that atracurium can provoke mast cell degranulation directly, not through histamine-releasing receptors, and clinicians often choose slower administration or an alternative agent if histamine-related effects are a concern.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy